1984•Drug and Therapeutics BulletinRequires access

Medical treatment of gallstones: ursodeoxycholic acid

Author information unavailable

Abstract

We discussed the dissolution of gallstones with chenodeoxycholic acid (CDCA) (Chendol - CP Pharmaceuticals; Chenofalk - Thames) five years ago.1 Now a second drug, ursodeoxycholic acid (UDCA) (Destolit - Merrell; Ursofalk - Thames) is available for the same purpose. Like CDCA it is given by mouth to dissolve non-calcified cholesterol gallstones in the gallbladder. Several potential advantages are claimed for UDCA; what is its place in treatment?

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Ursodeoxycholic acid, Gallstones, Chenodeoxycholic acid, Gastroenterology, Medicine, Internal medicine, Gallbladder, Bile acid